Browsing by Author "Pintos Morell, Guillem"
Now showing items 1-6 of 6
-
Biomarkers in Fabry Disease: Implications for Clinical Diagnosis and Follow-up
Carnicer Cáceres, Clara; Arranz Amo, José Antonio; Cea Arestín, Cristina; Camprodon Gomez, Maria; Moreno Martinez, David; Lucas del Pozo, Sara; Moltó Abad, Marc Miquel; Tigri-Santiña, Ariadna; Agraz Pamplona, Irene; Hernández Vara, Jorge; Armengol Bellapart, Mar; del Toro Riera, Mireia; Pintos Morell, Guillem; Rodríguez Palomares, Jose Fernando (MDPI, 2021-04-13) -
Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis
Ramaswami, Uma; Beck, Michael; Hughes, Derralynn; Kampmann, Christoph; Botha, Jaco; Pintos Morell, Guillem (Dove Medical Press, 2019-10-25) -
Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1
Koehorst, Emma; Núñez-Manchón, Judit; Ballester-López, Alfonsina; Almendrote, Miriam; Lucente, Giuseppe; Arbex, Andrea; Pintos Morell, Guillem (MDPI, 2021-12) -
Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
Quijada‑Fraile, Pilar; Arranz Canales, Elena; Martín‑Hernández, Elena; Ballesta‑Martínez, María Juliana; Guillén‑Navarro, Encarna; Pintos Morell, Guillem; Moltó Abad, Marc Miquel; Moreno Martinez, David (BMC, 2021-11-03) -
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
Couce, Maria Luz; Sánchez-Pintos, Paula; Aldámiz-Echevarría, Luís; Vitoria, Isidro; Navas-López, Víctor Manuel; Martín-Hernández, Elena; Pintos Morell, Guillem (Wolters Kluwer Health, Inc., 2019-09-01) -
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry
Beck, Michael; Ramaswami, Uma; Hernberg‑Ståhl, Elizabeth; Hughes, Derralynn; Kampmann, Christoph; Mehta, Atul; Pintos Morell, Guillem (BMC, 2022-06-20)